About a year ago, Anna DeLaRosby, PT, DPT, had a question for her former classmates from physical therapy school. A 2008 graduate of Clarke University, she had gone on to work at several different clinics and to become a physical therapy instructor herself.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Weighty Matters: Physical Therapy and GLP-1 Medications
What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.
Date: Friday, August 1, 2025
Author:
Chris Hayhurst
Share This
Resource Details
Date: August 1, 2025
Contact: aptamag@apta.org
Content Type: Feature
Topics
Author(s)
Chris Hayhurst
You Might Also Like...
Feature
Neuroplasticity: The Science, the Spark, and the Everyday Work
Better brain, better outcomes. Why neuroplasticity matters in every physical therapy session.
Feature
How PT-PTA Teams Are Expanding Access to Care
Physical therapists and physical therapist assistants are redefining collaboration to improve access, efficiency, and patient outcomes.
Article
APTA Master Class Series Brings Immersive, In-Person Learning to PTs and PTAs
The physical therapy profession continues to evolve in response to new technologies, changing payment models, emerging practice opportunities, and shifting